“antibiotics” Archives

in
Entry Author Date Location
Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists 08/14/17 Boston
Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger 08/09/17 Raleigh Durham
Tetraphase Claws Back From Failed Study, Eyes FDA Filing With New Data 07/26/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
SRI’s Michigan Office Will Help Develop New VEE Vaccine 05/15/17 Detroit Ann Arbor
Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs 04/25/17 San Diego
Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals 04/06/17 San Diego
With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval 04/03/17 Boston
Cempra Soars on Drug’s Potential to Treat MRSA, Other Infections 02/24/17 Raleigh Durham
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle 06/16/16 Boston
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Spero Rolls up More Antibiotics With Vertex Deal 05/25/16 Boston
East Coast Biotech Roundup: PfizerGan, Nimbus, Intercept, Tesaro & More 04/08/16 Boston
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
Former Cubist CEO Mike Bonney Joins Third Rock Ventures 01/07/16 Boston
To Fight “Superbugs,” Roche Shells Out $190M For Bay Area’s GeneWEAVE 08/13/15 San Francisco
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
With $30M, Spero Broadens Fight Against Drug-Resistant Bugs 06/08/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Admetsys Wins Top Prize at SXSW Hatch Pitch, Astroprint and Plum Follow 03/16/15 Texas
Antibiotics Startup Gets $22M From Roche, Others, For New “Macrolides” 03/04/15 Boston
“21st Century Cures” By Year’s End? Its Backers Want More Ideas 02/09/15 National
Independent No More: Cubist Sold to Merck for $9.5B 12/08/14 Boston
Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug 10/06/14 Texas
With FDA Nod, T2 Bio’s Sepsis Test Heads to Commercial Proving Ground 09/23/14 Boston
Cempra Milestone Highlights Experimental Antibiotic’s Potential 09/09/14 Raleigh Durham
Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs 07/22/14 Boston
San Diego Biotech Raises Over $30M to Fight Deadly Fungal Infections 06/25/14 San Diego
Page 1 of 6 next page »